Trial for malaria vaccine
BioNTech SE (BioNTech) announced on Dec 23, 2022, the initiation of a first-in-human Phase 1 study with BNT165b1, the first candidate ...
Read moreBioNTech SE (BioNTech) announced on Dec 23, 2022, the initiation of a first-in-human Phase 1 study with BNT165b1, the first candidate ...
Read moreRevon Media Sdn Bhd
A-5-1, Block A, Parklane Commercial Hub,
Jalan SS 7/26, SS7, 47301 Petaling Jaya,
Selangor Darul Ehsan, Malaysia.
Tel: +603 7886 6091
Fax: +6 03 3358 0303
Copyright © 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd. About Us | Contact Us | Privacy Policy | Terms of use